Angiotensin converting enzyme inhibitors are associated with the need for increased recombinant human erythropoietin maintenance doses in hemodialysis patients

Nephron

Volumn 77, Issue 2, 1997, Pages 164-168

  Matsumura, Masami ^a   Nomura, Hideki ^a   Koni, Ichiro ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme inhibitors; Hemodialysis; Recombinant human erythropoietin; Renal anemia

Indexed keywords

ALUMINUM; CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; CANCER; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPARATHYROIDISM; INFECTION; IRON BINDING CAPACITY; IRON DEFICIENCY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE;

EID: 0030783007     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190268     Document Type: Article

References (30)

1. Gavras H, Gavras I: Angiotensin converting enzyme inhibitors: Properties and side effects, Hypertension 1988:11 (suppl II):37-41.
2. Weber MA: Safety issues during antihypertensive treatment with angiotensin converting cn-zvme inhibitors, Am J Med 1988:84(suppl 4A): 16-23.
3. Malsumura M, llaruki K, Kajinami K, Takada T: Angioedema likely related to angiotensin converting enzyme inhibitors, Intern Med 1993:32:424-426.
4. Hirakata H, Onoyama K, Iseki K, Kumagai H, Fujimi S, Omac T: Worsening of anemia induced by long-term use of captopril in hemodialysis patients, Am J Nephrol 1984:4:355-360.
5. Gaston RS, Julian BA, Curtis JJ: Posttransplant erythrocvtosis: An enigma revisited, Am J Kidney Dis 1994:24:1-11.
6. Eschbach JW, Egric JC, Downing MR, Browne JK, Adamson JW: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: Results of combined phase I and II clinical trial, N Engl J Med 1987: 316:73-78.
7. Van Wyck DB, Stivclman C, Ruiz J, Kirlin LF, Katz MA, Ogden DA: Iron status in patients receiving ery thropoietin for dialysis-associated anemia, Kidney Int 1989;35:712-716.
8. Muirhcad N, Bargman J, Burgess E, Jindal KK, Levin A, Nolin L, Parfrev P: Evidence-based recommendations for the clinical use of recombinant human erythropoietin, Am J Kidney Dis 1995:26(suppl 1):1-24.
9. Sudhaker Rao D, Shih M, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia, N Engl J Med 1993;328:171-175.
10. Kooistra MP, Struyvcnberg A, van Es A: The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels, Nephron 1991:57:127-128.
11. Matsumura M, Hatakeyama S, Koni I, Mabu-chi H, Muramoto H: Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients, Nephron 1996:72:574-578.
12. Chandra M, Miller ME, Garcia JF, Mossey RT, McViear M: Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients, Nephron 1985:39:26-29.
13. Ali M, Rigolosi R, Faycmi AO, Braun EV, Frascino J, Singer R: Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy, Lancet 1982;1:652-655.
14. Kooistra MP, van Es, A, Struyvcnberg A, Marx JJM: Iron metabolism in patients with the anemia of end-stage renal disease during treatment with recombinant human erythropoietin, Br J Haematol 1991:79:634-639.
15. Lee Mi L, Means RT: Extremely elevated serum ferritin levels in a university hospital: Associated diseases and clinical significance, Am J Med 1995:98:566-571.
16. Mcisels IS, Rov-Chaudhury P: Serum ferritin level in hemodialysis patients, Nephron 1996: 72:496.
17. Matsumoto K, Yamada Y, Takahashi M, To-doroki T, Mizoguchi K, Misaki H, Yuki H: Flu-orometric determination of carnitine in scrum with immobilized carnitine dehydrogenase and diaphorase, Clin Chem 1990:36:2072-2076.
18. Takahashi M, Ueda S, Misaki H, Sugiyama N, Matsumoto K, Matsuo N, Murao S: Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase, Clin Chem 1994;40:817-821.
19. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS), Kidney lnt 1985:28:526-534.
20. Fried W, Barone-Varelas J, Barone T, Ana-gnostou A: Effect of angiotensin infusion on cxlrarcnal erythropoietin production, J Lab Clin Med 1982:99:520-525.
21. Vlahakos DV, Balodimos C, Papachristopou-los V, Vassilakos P, Hinari E, Vlachojannis JG: Rcnin-angiotcnsin system stimulates erythropoietin secretion in chronic hemodialysis patients, Clin Nephrol 1995:43:53-59.
22. Hirakata H, Onoyama K, Hori K, Fujishima M: Participation of the rcnin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients, Clin Nephrol 1986:26:27-32.
23. Julian BA, Gaston RS, Barker CV, Krystal G, Diethclm AG, Curtis JJ: Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis, Kidney Int 1994:46:1397-1403.
24. Roodman GD, Johnson RA, Clibon U: Tumor necrosis factor u and the anemia ofchronic disease: Effects of chronic exposure to TNF on erythropoiesis in vivo, Adv Exp Med Biol 1989:271:185-196.
25. Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW: Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis, Lancet 1988;2:706-709.
26. Macdougall IC, Allen DA, Tucker B, Baker LRI, Rain AEG: Serum interlcukin-6 levels are a useful indicator of marrow suppression in patients with resistance to erythropoietin due to inflammatory disease, J Am Soc Nephrol 1993:4:428.
27. Ooi BS, Darocy AF, Poliak VE: Scrum transferrin levels in chronic renal failure, Nephron 1972.9:200-207.
28. Trovato GM, Ginardi V, Di Marco V, Dcll’Aira AE, Corsi M: Long-term /.-carnitine treatment of chronic anemia of patients with end-stage renal failure, Curr Thcr Res 1982:31: 1042-1049.
29. Labonia WD: Carnitine effects on anemia in hemodialyzcd patients treated with erythropoietin, Am J Kidney Dis 1995;26:757-764.
30. Arduini A, Mancinelli G, Radatti GL, Dottori S, Molajoni F, Ramsay RR: Role of carnitine and carnitine palmitoyltransferase as integral components of the pathway for membrane phospholipid fatly acid turnover in intact human erythrocytes, J Biol Chem 1992:267: 12673-12681.